Analytical and Clinical Performance of the Panbio COVID-19 Antigen-Detecting Rapid Diagnostic Test.

Viral Infections, Non-HIV

Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis

J Clin Virol.

Scohy A, Anantharajah A, Bodéus M, Kabamba-Mukadi B, Verroken A, Rodriguez-Villalobos H

doi: 10.1016/j.jcv.2020.104455.

Further Publications Infectiology

Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients

Clin Microbiol Infect

Torres I, Poujois S, Albert E, Colomina J, Navarro D

doi: 10.1016/j.cmi.2020.12.022

Further Publications Infectiology

Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives

Clin Microbiol Infect

Hingrat QL, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y, Duval X, Burdet C, Ichou H, Damond F, Bertine M, Benmalek N, French COVID cohort management committee, CoV-CONTACT study group., members of the French-COVID cohort study group (by alphabetical order)., member of the CoV-CONTACT study group. Principal investigator., Steering Committee., CoV-CONTACT Clinical Centers., Coordination and statistical analyses., Virological Lab., Biological Center., Partners., Sponsor., Genetic.

doi: 10.1016/j.cmi.2020.11.025

Viral Infections, Non-HIV

Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison

J Infect

Baro B, Rodo P, Ouchi D, Bordoy AE, Saya Amaro EN, Salsench SV, Molinos S, Alemany A, Ubals M, Corbacho-Monné M, Millat-Martinez P, Marks M, Clotet B, Prat N, Ara J, Vall-Mayans M, G-Beiras C, Bassat Q, Blanco I, Mitjà O

doi: 10.1016/j.jinf.2021.04.009

Viral Infections, Non-HIV

Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape

Biosens Bioelectron

Ravi N, Cortade DL, Ng E, Wang SX

doi: 10.1016/j.bios.2020.112454

Viral Infections, Non-HIV

Nasopharyngeal Panbio COVID-19 Antigen Performed at Point-of-Care Has a High Sensitivity in Symptomatic and Asymptomatic Patients With Higher Risk for Transmission and Older Age

Open Forum Infect Dis

Masiá M, Fernández-González M, Sánchez M, Carvajal M, García JA, Gonzalo-Jiménez N, Ortiz de la Tabla V, Agulló V, Candela I, Guijarro J, Gutiérrez JA, de Gregorio C, Gutiérrez F

doi: 10.1093/ofid/ofab059

Viral Infections, Non-HIV

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

J Clin Virol.

Nicol T, Lefeuvre C, Serri O, Pivert A, Joubaud F, Dubée V, Kouatchet A, Ducancelle A, Lunel-Fabiani F, Le Guillou-Guillemette H

doi: 10.1016/j.jcv.2020.104511.

Viral Infections, Non-HIV

Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19

J Infect.

Clark TW, Brendish NJ, Poole S, Naidu VV, Mansbridge C, Norton N, Wheeler H, Presland L, Ewings S

doi: 10.1016/j.jinf.2020.06.051.

Viral Infections, Non-HIV

Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?

J Med Virol.

Güemes-Villahoz N, Burgos-Blasco B, Vilela AA, Arriola-Villalobos P, Luna CMR, Sardiña RC, Delgado-Iribarren A, García-Feijoó J

doi: 10.1002/jmv.26219.

Related content

Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis

Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients

Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives

Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison

Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape

Nasopharyngeal Panbio COVID-19 Antigen Performed at Point-of-Care Has a High Sensitivity in Symptomatic and Asymptomatic Patients With Higher Risk for Transmission and Older Age

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19

Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?